Capital Management Associates (New York)’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Capital Management Associates (New York)’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q1	–	Sell	-18,000	Closed	-$217K	–	155
2014 Q4	$217K	Sell	18,000 -1,500	-8%	-$17.1K	0.32%	118
2014 Q3	$221K	Buy	19,500 +165	+0.9%	+$1.88K	0.33%	127
2014 Q2	$234K	Buy	+19,335	New	+$228K	0.34%	126

Other funds holding MNTA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.14% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

DCM

Discovery Capital Management South Norwalk, Connecticut $1.92B AUM 218.96% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TAM

Tocqueville Asset Management New York $7.56B AUM 44.87% 1-Year Est. Return

SAM

Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return

Capital Management Associates (New York)'s MNTA Position: Q1 2015 in Review

Capital Management Associates (New York) sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q1 2015, closing a stake of 18,000 shares — an estimated $217K sold.

Capital Management Associates (New York) first reported a position in MNTA in Q2 2014 and held it in 3 quarters. The position peaked at $234K in Q2 2014. 143 funds tracked by Wall St. Rank hold MNTA as of Q1 2015.

Capital Management Associates (New York) reported no remaining Momenta Pharmaceuticals, Inc. position as of Q1 2015 after selling out during the quarter.
Capital Management Associates (New York) sold 18,000 Momenta Pharmaceuticals, Inc. shares in Q1 2015, an estimated $217K.
Capital Management Associates (New York) first reported a position in Momenta Pharmaceuticals, Inc. in Q2 2014 and held it in 3 quarters.
Capital Management Associates (New York)'s Momenta Pharmaceuticals, Inc. position peaked at $234K in Q2 2014.
143 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q1 2015.

Based on Capital Management Associates (New York)'s 13F filing for Q1 2015, filed 21 May 2015.